[{"NetIncomeLoss_1_Q1_USD":-30359000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.01,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-121730000.0,"DebtInstrumentInterestRateDuringPeriod_1_Q1_pure":0.0807,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":266724.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":407000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":64000.0,"AssetsCurrent_0_Q1_USD":266001000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-39000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8205947.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":1360000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-129000.0,"EquitySecuritiesFvNi_0_Q1_USD":30955000.0,"CommonStockSharesIssued_0_Q1_shares":46103606.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":292846000.0,"Assets_0_Q1_USD":358528000.0,"ShareBasedCompensation_1_Q1_USD":3952000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":10718984.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":15.13,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":3060000.0,"InterestPaidNet_1_Q1_USD":331000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.849,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":45907590.0,"InterestPayableCurrentAndNoncurrent_0_Q1_USD":200000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-10689000.0,"ProceedsFromStockPlans_1_Q1_USD":873000.0,"AccountsReceivableNetCurrent_0_Q1_USD":7227000.0,"CommonStockValue_0_Q1_USD":46000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1291000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-4327000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1826000.0,"InvestmentIncomeNonoperating_1_Q1_USD":197000.0,"IncreaseDecreaseInDeferredCharges_1_Q1_USD":-1050000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-30488000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-462000.0,"OtherAssetsNoncurrent_0_Q1_USD":2211000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":55818000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":565524000.0,"Liabilities_0_Q1_USD":51190000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q1_shares":4445.0,"RevenueFromRelatedParties_1_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"MarketableSecuritiesCurrent_0_Q1_USD":164455000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":11107000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":4496000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":14660000.0,"OperatingIncomeLoss_1_Q1_USD":-19009000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":1900000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3952000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-30430000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":74615000.0,"LiabilitiesCurrent_0_Q1_USD":22660000.0,"AccountsPayableCurrent_0_Q1_USD":5891000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":56690000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7546000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.846,"ProceedsFromStockOptionsExercised_1_Q1_USD":1360000.0,"LongTermDebtNoncurrent_0_Q1_USD":24680000.0,"InterestExpenseDebt_1_Q1_USD":600000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1_Q1_USD":0.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":84600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":56690000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.006,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":257834.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":873000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":809000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":14829000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":407000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":65000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":164604000.0,"RestrictedCashNoncurrent_0_Q1_USD":872000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":12088000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":358528000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3952000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":100000.0,"OperatingExpenses_1_Q1_USD":33669000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.66,"ProfitLoss_1_Q1_USD":-30359000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":638000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":22562000.0,"OtherLiabilitiesCurrent_0_Q1_USD":185000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":822000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":292845000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-496000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":2390000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-267000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4445.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-258232000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-150334000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1668000.0,"CommonStockSharesOutstanding_0_Q1_shares":46103606.0,"StockholdersEquity_0_Q1_USD":307338000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-7793000.0,"Ticker":"STRO","CIK":"1382101","name":"SUTRO BIOPHARMA, INC.","OfficialName":"Sutro Biopharma Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"326059920.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]